1 / 43

A beginners guide to SLE

A beginners guide to SLE. Dr Mike Martin St James’s Univ. Hosp. Systemic Lupus Erythematosus. 1. Autoimmune, inflammatory, multisystem disease 2. Associated with pathogenic autoantibodies resulting in immune complex formation and complement mediated tissue damage

ciqala
Télécharger la présentation

A beginners guide to SLE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A beginners guide to SLE Dr Mike Martin St James’s Univ. Hosp.

  2. Systemic Lupus Erythematosus 1. Autoimmune, inflammatory, multisystem disease 2. Associated with pathogenic autoantibodies resulting in immune complex formation and complement mediated tissue damage 3. Characterised by remissions & relapses 4. Variable course and prognosis

  3. Auto-immune disease • Antibody producing cells (lymphocytes and plasma cells) are presented with antigen. • The antigen-antibody complex will be coated in compliment (C3 + C4) – opsonisation. • These circulating complexes are normally removed by the reticulo-endothelial system. • In auto-immune disease these complexes locate to certain tissues and cause damage and disease.

  4. Factors contributing to autoimmune disease eg SLE • Genetic • Hormonal • Environmental • Stress

  5. SLE is more common in • women • Afro-Caribbean and Asians Irrespective of • country of birth • social class • place of residence Johnson et al. Arthritis Rheum. 1995. 38: 551-558

  6. Epidemiology • Prevalence • total: 28/100,000 • female 50/100,000 = 1/2000 • In women: Afro-Carib1/500; Asian 1/1,000; Caucasian 1/2,500 • Incidence: total 4/100,000 • female 7/100,000

  7. Immunology • The ready detection of numerous antibodies to cellular components of the nucleus, cytoplasm and cell membrane has led to the concept that lupus is an auto-immune disease. The major immune response appears to be directed against nuclear antigens. These anti-nuclear antibodies are responsible for the LE cells and immuno-fluorescence on tissue sections.

  8. Lupus band test

  9. High probability of SLE • photosensitivity • arthralgia and rash • Raynaud’ or mouth ulcers • pleurisy • proteinuria • haematologicl abnormalities • abortion • any neurological disorder • fatigue / depression

  10. Triggers for SLE • Oestrogens • Sunlight • Infection • Pregnancy • Surgery

  11. SLE: presenting clinical features. Arthritis or arthralgia 55% Skin involvement 20% Nephritis 5% Fever 5% Other 15%

  12. SLE - Non-specific features • Fatigue • Muscle pains • Lymphadenoapthy • Fever • Loss of appetite • Weight loss

  13. Organ involvement in SLE • Joints 90% • Skin • rashes 70% • discoid lesions 30% • alopecia 40% • pleuro-pericardium 60% • kidney 50% • Raynaud’s 20% • mucous membranes 15% • CNS (psychosis/convulsions) 15%

  14. Classification criteria for diagnosis of SLE (>4 of 11) • Neurological disorder • seizure or psychosis • Haematologic disorder • haemolytic anaemia • leukopenia, lymphopenia • thrombocytopenia • Immunological disorder • anti-DNA, anti-Sm • anti-cardiolipin • ANA positivity • Malar rash • Discoid rash • Photosensitivity • Oral ulcers • Arthritis • Serositis • Renal disorder • proteinuria > 0.5g • cells &/or casts

  15. 4. Oral ulcers

  16. 5. Serositis

  17. 6. Arthritis -arthralgia -symmetrical, non-erosive synovitis -Jacoub’s arthropathy (reducible deformities) -Nodules possible

  18. Raynaud’s phenomenon Livedo reticularis Alopecia diffuse or patchy

  19. 7.Renal disease - consider biopsy if: Proteinuria > 0.5 g/24 hours red or white cells in urine casts creatinine clearance reduced (<80ml/min) Proliferative glomerulonephritis Membranous glomerulonephritis

  20. 7. Renal disease • Always check urine for protein and blood • Exclude infection/menstruation/ kidney stones • Check serum creatinine/creatinine clearance • Exclude drugs (NSAIDS) • Monitor blood pressure

  21. 8. Neurological disease • Peripheral and/or central nervous system • SLE is great mimic • Hemiplegic migraine • Young stroke • Epilepsy • Aseptic meningitis

  22. Cerebral Lupus • Cerebral LE is a serious condition occuring in up to 1 in 6 of SLE patients and can cause prolonged headaches, seizures, strokes, acute psychotic episodes and severe depression. Anyone with cognitive functional defects should be referred for specialist advice.

  23. 9. Haematological clues • Leucopenia (lymphopenia > neutropenia) • Thrombocytopenia • Anaemia- not iron deficient • Tests for haemolysis- Coomb’s test haptoglobins reticulocytes

  24. 10. Immunological screening tests • CRP versus ESR/viscosity • ANA • RF • IgG, IgA, IgM

  25. 11. ANA - Indirect immunofluorescence 1 1 1 • Top left: homogenous Top right: peripheral • Bottom left: speckled Bottom right: nucleolar

  26. Differential diagnosis of SLE • RA • Other autoimmune/connective tissue disease • Infection • Drug-induced condition • Malignancy • Post-viral fatigue syndrome • Fibromyalgia

  27. Further immunological tests • For SLE: anti-dsDNA Abs anti-ENA Abs (Ro, La, RNP, Sm) C3, C4, C3d • For anti-phospholipid syndrome: anti-cardiolipin Abs APTT/Lupus anticoagulant test • (detects prolongation of phospholipid dependent coagulation tests due to antibodies acting as inhibitors of clotting test, despite causing thrombosis in vivo- not reversed by addition of normal serum)

  28. Auto antibodies in SLE to: • dsDNA • 60% patients • increased risk kidney disease • levels fluctuate • RIA, ELISA, Crithidia

  29. Cardiolipin 10–30% Thrombosis Foetal loss Histone Drug induced lupus Sm 10-30% ?kidney and CNS disease RNP 10-30% “Mixed connective tissue disease” (lupus, systemic sclerosis and myositis) Auto antibodies in SLE to:

  30. Ouchterlony – Passive immunodiffusion • Ro and La • 20-60% and 15-40% • rashes & neonatal lupus and congenital heart block

  31. Antiphospholipid antibody syndrome Recurrent venous or arterial thrombosis Recurrent miscarriages Thrombocytopenia Anti-cardiolipin antibodies Circulating lupus anticoagulant (APTT, KCT, Russel Viper Venom test)

  32. Treatment • Sun-block lotions/creams • Artificial tears and saliva • NSAID’s • Corticosteroids • Hydroxychloroquine • Immunosuppressants • Warfarin • Rituximab

  33. Survival rates in SLE 5 years 10 years 15 years 20 years (Abu-Shakra J Rheum 1995) 93% 85% 79% 68%

  34. Primary causes of death in early and late SLE Early Active SLE 26% Infections 37% Other morbidity 19% Unrelated 7% Unknown 11% (Abu-Shakra J Rheum 1995) Late 10% 30% 37% 13% 10%

  35. Other points of interest in SLE • Raynaud’s disease • Septic arthritis • Cardiovascular risk • Osteoporosis • Thrombosis • Malignancy

  36. The End

More Related